A single deletion at position 134, 135, or 136 in the beta 7-beta 8 loop of the p51 subunit of HIV-1 RT disrupts the formation of heterodimeric enzyme

Journal of Cellular Biochemistry

Volumn 109, Issue 3, 2010, Pages 598-605

  Upadhyay, Alok ^a   Pandey, Nootan ^a   Mishra, Chaturbhuj A ^a   Talele, Tanaji T ^a,b   Pandey, Virendra N ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b ST JOHN'S UNIVERSITY   (United States)

Author keywords

Dimerization; HIV 1; Reverse transcription

Indexed keywords

ALANINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ASPARAGINE; HETERODIMER; ISOLEUCINE; PROTEIN P51; PROTEIN P66; RNA DIRECTED DNA POLYMERASE; SERINE;

ARTICLE; BETA CHAIN; DELETION MUTANT; DIMERIZATION; DRUG TARGETING; ENZYME STABILITY; ENZYME SUBUNIT; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; BINDING SITES; DIMERIZATION; HIV REVERSE TRANSCRIPTASE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, SECONDARY; PROTEIN SUBUNITS; SEQUENCE DELETION; STRUCTURE-ACTIVITY RELATIONSHIP;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 74949086940     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22439     Document Type: Article

References (27)

1. Arts EJ, Li X, Gu Z, Kleiman L, Parniak MA, Wainberg MA. 1994. Comparison of deoxyoligonucleotide and tRNA(Lys-3) as primers in an endogenous human immunodeficiency virus-1 in vitro reverse transcription/template-switching reaction. J Biol Chem 269:14672-14680.
2. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JS, Smith JA, Struhl K. 1987. Current protocols in molecular biology. NY: Greene Publishing Associates and Wiley-Intersciences, John Wiley & Sons.
3. Auwerx J, Van Nieuwenhove J, Rodriguez-Barrios F, de Castro S, Velazquez S, Ceccherini-Silberstein F, De Clercq E, Camarasa MJ, Perno CF, Gago F, Balzarini J. 2005. The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugs. FEBS Lett 579:2294-2300.
4. Balzarini J, Auwerx J, Rodriguez-Barrios F, Chedad A, Farkas V, Ceccherini-Silberstein F, Garcia-Aparicio C, Velazquez S, De Clercq E, Perno CF, Camarasa MJ, Gago F. 2005. The amino acid Asn136 in HIV-1 reverse transcriptase (RT) maintains efficient association of both RT subunits and enables the rational design of novel RT inhibitors. Mol Pharmacol 68:49-60.
5. Basavapathruni A, Anderson KS. 2007. Reverse transcription of the HIV-1 pandemic. FASEB J 21:3795-3808.
6. Boyer PL, Tantillo C, Jacobo-Molina A, Nanni RG, Ding J, Arnold E, Hughes SH. 1994. Sensitivity of wild-type human immunodeficiency virus type 1 reverse transcriptase to dideoxynucleotides depends on template length; the sensitivity of drug-resistant mutants does not. Proc Natl Acad Sci USA 91:4882-4886.
7. Depollier J, Hourdou ML, Aldrian-Herrada G, Rothwell P, Restle T, Divita G. 2005. Insight into the mechanism of a peptide inhibitor of HIV reverse transcriptase dimerization. Biochemistry 44:1909-1918.
8. Harris D, Lee R, Misra HS, Pandey PK, Pandey VN. 1998. The p51 subunit of human immunodeficiency virus type 1 reverse transcriptase is essential in loading the p66 subunit on the template primer. Biochemistry 37:5903-5908.
9. Hostomsky Z, Hostomska Z, Fu TB, Taylor J. 1992. Reverse transcriptase of human immunodeficiency virus type 1: Functionality of subunits of the heterodimer in DNA synthesis. J Virol 66:3179-3182.
10. Hottiger M, Podust VN, Thimmig RL, McHenry C, Hubscher U. 1994. Strand displacement activity of the human immunodeficiency virus type 1 reverse transcriptase heterodimer and its individual subunits. J Biol Chem 269:986-991.
11. Hsieh JC, Zinnen S, Modrich P. 1993. Kinetic mechanism of the DNA-dependent DNA polymerase activity of human immunodeficiency virus reverse transcriptase. J Biol Chem 268:24607-24613.
12. Huang H, Chopra R, Verdine GL, Harrison SC. 1998. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: Implications for drug resistance. Science 282:1669-1675.
13. Jacobo-Molina A, Ding J, Nanni RG, Clark AD, Jr., Lu X, Tantillo C, Williams RL, Kamer G, Ferris AL, Clark P, et al. 1993. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. Proc Natl Acad Sci USA 90:6320-6324.
14. Jacques PS, Wohrl BM, Howard KJ, Le Grice SF. 1994. Modulation of HIV-1 reverse transcriptase function in "selectively deleted" p66/p51 heterodimers. J Biol Chem 269:1388-1393.
15. Kohlstaedt LA, Wang J, Friedman JM, Rice PA, Steitz TA. 1992. Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256:1783-1790.
16. Le Grice SF, Gruninger-Leitch F. 1990. Rapid purification of homodimer and heterodimer HIV-1 reverse transcriptase by metal chelate affinity chromatography. Eur J Biochem 187:307-314.
17. Le Grice SF, Naas T, Wohlgensinger B, Schatz O. 1991. Subunit-selective mutagenesis indicates minimal polymerase activity in heterodimer-associated p51 HIV-1 reverse transcriptase. EMBO J 10:3905-3911.
18. Levine JG, Hatfield D, Oroszlan S, Rein A. 1993. Mechanisms of translational suppression used in the biosynthesis of reverse transcriptase. In: Skalka AM, Goff SP, editors. Reverse transcriptase. Plainview, NY: Cold Spring Harbor Laboratory Press.
19. Loya S, Gao HQ, Avidan O, Boyer PL, Hughes SH, Hizi A. 1997. Subunit-specific mutagenesis of the cysteine 280 residue of the reverse transcriptase of human immunodeficiency virus type 1: Effects on sensitivity to a specific inhibitor of the RNase H activity. J Virol 71:5668-5672.
20. Misra HS, Pandey PK, Pandey VN. 1998. An enzymatically active chimeric HIV-1 reverse transcriptase (RT) with the RNase-H domain of murine leukemia virus RT exists as a monomer. J Biol Chem 273:9785-9789.
21. Mous J, Heimer EP, Le Grice SF. 1988. Processing protease and reverse transcriptase from human immunodeficiency virus type I polyprotein in Escherichia coli. J Virol 62:1433-1436.
22. Mulky A, Vu BC, Conway JA, Hughes SH, Kappes JC. 2007. Analysis of amino acids in the beta7-beta8 loop of human immunodeficiency virus type 1 reverse transcriptase for their role in virus replication. J Mol Biol 365:1368-1378.
23. Pandey VN, Kaushik N, Rege N, Sarafianos SG, Yadav PN, Modak MJ. 1996. Role of methionine 184 of human immunodeficiency virus type-1 reverse transcriptase in the polymerase function and fidelity of DNA synthesis. Biochemistry 35:2168-2179.
24. Pandey PK, Kaushik N, Talele TT, Yadav PN, Pandey VN. 2001. The beta7-beta8 loop of the p51 subunit in the heterodimeric (p66/p51) human immunodeficiency virus type 1 reverse transcriptase is essential for the catalytic function of the p66 subunit. Biochemistry 40:9505-9512.
25. Pandey PK, Kaushik N, Singh K, Sharma B, Upadhyay AK, Kumar S, Harris D, Pandey VN. 2002. Insertion of a small peptide of six amino acids into the beta7-beta8 loop of the p51 subunit of HIV-1 reverse transcriptase perturbs the heterodimer and affects its activities. BMC Biochem 3:18.
26. Sanger F, Nicklen S, Coulson AR. 1977. DNA sequencing with chain-erminating inhibitors. Proc Natl Acad Sci USA 74:5463-5467.
27. Sierra S, Kupfer B, Kaiser R. 2005. Basics of the virology of HIV-1 and its replication. J Clin Virol 34:233-244.